We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Board of Directors

Dr. Severin Schwan
Chairman, Genentech Board of Directors
Chief Executive Officer, Roche Group

Bill Anderson
Chief Executive Officer, Roche Pharmaceuticals

Alexander Hardy
Chief Executive Officer, Genentech

Aviv Regev
Executive Vice President, Research and Early Development, Genentech

Levi Garraway
Chief Medical Officer, Executive Vice President and Head of Global Product Development, Roche and Genentech

Dr. Alan Hippe
Chief Financial Officer, Roche Group

André Hoffmann

Prof. Dr. Hans Clevers

Dr. Richard P. Lifton
President, The Rockefeller University

Secretary to the Genentech Board of Directors

Sean Johnston
Senior Vice President, General Counsel, Chief Compliance Officer, Corporate Secretary and Head of Legal Affairs, Pharma North America